ADAM-17, another key regulator in cellular processes, has been shown to increase in the upper respiratory tract, where it modulates the release of soluble ACE2 (sACE2) and stimulates Th17 immune responses, further contributing to inflammation in COVID-19 [18]. This evidence concerns the gene ADAM17 and COVID-19.